annual CFF:
-$48.92M+$38.60M(+44.10%)Summary
- As of today (May 24, 2025), AMED annual cash flow from financing activities is -$48.92 million, with the most recent change of +$38.60 million (+44.10%) on December 31, 2024.
- During the last 3 years, AMED annual CFF has fallen by -$104.05 million (-188.75%).
- AMED annual CFF is now -116.22% below its all-time high of $301.57 million, reached on December 31, 2008.
Performance
AMED Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
-$13.30M-$2.10M(-18.70%)Summary
- As of today (May 24, 2025), AMED quarterly cash flow from financing activities is -$13.30 million, with the most recent change of -$2.10 million (-18.70%) on March 31, 2025.
- Over the past year, AMED quarterly CFF has dropped by -$4.75 million (-55.56%).
- AMED quarterly CFF is now -103.45% below its all-time high of $385.21 million, reached on March 31, 2008.
Performance
AMED quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
-$53.67M-$4.75M(-9.71%)Summary
- As of today (May 24, 2025), AMED TTM cash flow from financing activities is -$53.67 million, with the most recent change of -$4.75 million (-9.71%) on March 31, 2025.
- Over the past year, AMED TTM CFF has dropped by -$14.49 million (-36.98%).
- AMED TTM CFF is now -113.85% below its all-time high of $387.46 million, reached on March 31, 2008.
Performance
AMED TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
AMED Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +44.1% | -55.6% | -37.0% |
| 3 y3 years | -188.8% | -79.7% | -151.0% |
| 5 y5 years | -121.5% | -109.1% | -172.5% |
AMED Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -188.8% | +44.1% | -403.6% | +76.6% | -135.6% | +40.7% |
| 5 y | 5-year | -121.5% | +44.1% | -105.6% | +90.9% | -127.8% | +84.7% |
| alltime | all time | -116.2% | +81.7% | -103.5% | +90.9% | -113.8% | +84.7% |
AMED Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$13.30M(+18.7%) | -$53.67M(+9.7%) |
| Dec 2024 | -$48.92M(-44.1%) | -$11.21M(-25.7%) | -$48.92M(-4.3%) |
| Sep 2024 | - | -$15.09M(+7.2%) | -$51.14M(+20.9%) |
| Jun 2024 | - | -$14.08M(+64.7%) | -$42.31M(+8.0%) |
| Mar 2024 | - | -$8.55M(-36.3%) | -$39.18M(-55.2%) |
| Dec 2023 | -$87.52M(+187.6%) | -$13.43M(+114.7%) | -$87.52M(-3.2%) |
| Sep 2023 | - | -$6.25M(-42.9%) | -$90.44M(+4.2%) |
| Jun 2023 | - | -$10.95M(-80.7%) | -$86.83M(+8.6%) |
| Mar 2023 | - | -$56.89M(+248.1%) | -$79.92M(+162.6%) |
| Dec 2022 | -$30.43M(-155.2%) | -$16.34M(+518.9%) | -$30.43M(-66.2%) |
| Sep 2022 | - | -$2.64M(-34.7%) | -$90.03M(-159.6%) |
| Jun 2022 | - | -$4.05M(-45.3%) | $150.97M(+43.5%) |
| Mar 2022 | - | -$7.40M(-90.3%) | $105.18M(+90.8%) |
| Dec 2021 | $55.13M(-468.1%) | -$75.94M(-131.9%) | $55.13M(+59.2%) |
| Sep 2021 | - | $238.36M(-578.3%) | $34.62M(-109.9%) |
| Jun 2021 | - | -$49.83M(-13.3%) | -$350.47M(+60.4%) |
| Mar 2021 | - | -$57.46M(-40.4%) | -$218.48M(+1358.8%) |
| Dec 2020 | -$14.98M(-106.6%) | -$96.44M(-34.3%) | -$14.98M(-118.0%) |
| Sep 2020 | - | -$146.74M(-278.6%) | $83.36M(-56.8%) |
| Jun 2020 | - | $82.16M(-43.7%) | $193.10M(+160.7%) |
| Mar 2020 | - | $146.04M(+7590.5%) | $74.07M(-67.4%) |
| Dec 2019 | $227.21M(-185.0%) | $1.90M(-105.1%) | $227.21M(+28.3%) |
| Sep 2019 | - | -$37.00M(+0.3%) | $177.07M(+25.5%) |
| Jun 2019 | - | -$36.87M(-112.3%) | $141.11M(+301.1%) |
| Mar 2019 | - | $299.18M(-720.2%) | $35.18M(-113.2%) |
| Dec 2018 | -$267.42M(+4728.9%) | -$48.24M(-33.9%) | -$267.42M(+21.6%) |
| Sep 2018 | - | -$72.96M(-48.9%) | -$219.99M(+47.8%) |
| Jun 2018 | - | -$142.80M(+4063.1%) | -$148.84M(+1718.9%) |
| Mar 2018 | - | -$3.43M(+322.9%) | -$8.18M(+47.8%) |
| Dec 2017 | -$5.54M(-26.3%) | -$811.00K(-55.0%) | -$5.54M(+3.4%) |
| Sep 2017 | - | -$1.80M(-15.9%) | -$5.36M(+42.4%) |
| Jun 2017 | - | -$2.14M(+172.7%) | -$3.76M(-64.3%) |
| Mar 2017 | - | -$785.00K(+24.6%) | -$10.53M(+40.1%) |
| Dec 2016 | -$7.51M(-64.0%) | -$630.00K(+204.3%) | -$7.51M(-15.7%) |
| Sep 2016 | - | -$207.00K(-97.7%) | -$8.92M(+18.5%) |
| Jun 2016 | - | -$8.91M(-499.2%) | -$7.53M(+458.7%) |
| Mar 2016 | - | $2.23M(-209.9%) | -$1.35M(-93.6%) |
| Dec 2015 | -$20.89M(-129.6%) | -$2.03M(-271.7%) | -$20.89M(+32.0%) |
| Sep 2015 | - | $1.18M(-143.3%) | -$15.83M(-67.2%) |
| Jun 2015 | - | -$2.73M(-84.2%) | -$48.27M(-185.5%) |
| Mar 2015 | - | -$17.32M(-670.9%) | $56.45M(-20.0%) |
| Dec 2014 | $70.56M(-233.0%) | $3.03M(-109.7%) | $70.56M(+61.1%) |
| Sep 2014 | - | -$31.25M(-130.6%) | $43.81M(-39.1%) |
| Jun 2014 | - | $101.99M(-3286.1%) | $71.93M(-317.1%) |
| Mar 2014 | - | -$3.20M(-86.5%) | -$33.13M(-37.5%) |
| Dec 2013 | -$53.05M(+23.5%) | -$23.72M(+656.4%) | -$53.05M(+6.6%) |
| Sep 2013 | - | -$3.14M(+2.0%) | -$49.77M(-8.1%) |
| Jun 2013 | - | -$3.07M(-86.7%) | -$54.13M(-7.5%) |
| Mar 2013 | - | -$23.11M(+13.1%) | -$58.49M(+36.1%) |
| Dec 2012 | -$42.96M(+31.0%) | -$20.45M(+172.8%) | -$42.96M(+48.9%) |
| Sep 2012 | - | -$7.50M(+0.8%) | -$28.84M(-6.0%) |
| Jun 2012 | - | -$7.43M(-2.1%) | -$30.67M(-5.2%) |
| Mar 2012 | - | -$7.59M(+19.9%) | -$32.34M(-1.4%) |
| Dec 2011 | -$32.79M(-30.0%) | -$6.33M(-32.1%) | -$32.79M(-8.7%) |
| Sep 2011 | - | -$9.32M(+2.4%) | -$35.91M(-24.8%) |
| Jun 2011 | - | -$9.11M(+13.3%) | -$47.78M(+4.5%) |
| Mar 2011 | - | -$8.04M(-15.0%) | -$45.71M(-2.4%) |
| Dec 2010 | -$46.85M(-60.6%) | -$9.45M(-55.4%) | -$46.85M(+5.7%) |
| Sep 2010 | - | -$21.19M(+201.4%) | -$44.32M(+0.3%) |
| Jun 2010 | - | -$7.03M(-23.4%) | -$44.21M(-60.3%) |
| Mar 2010 | - | -$9.18M(+32.4%) | -$111.32M(-6.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2009 | -$118.77M(-139.4%) | -$6.93M(-67.1%) | -$118.77M(-16.2%) |
| Sep 2009 | - | -$21.08M(-71.6%) | -$141.75M(+3.5%) |
| Jun 2009 | - | -$74.14M(+346.2%) | -$136.93M(+36.6%) |
| Mar 2009 | - | -$16.62M(-44.4%) | -$100.26M(-133.2%) |
| Dec 2008 | $301.57M(+9300.5%) | -$29.91M(+84.0%) | $301.57M(-9.3%) |
| Sep 2008 | - | -$16.25M(-56.6%) | $332.54M(-4.6%) |
| Jun 2008 | - | -$37.48M(-109.7%) | $348.74M(-10.0%) |
| Mar 2008 | - | $385.21M(>+9900.0%) | $387.46M(>+9900.0%) |
| Dec 2007 | $3.21M(-95.5%) | $1.06M(-2130.8%) | $3.21M(-95.8%) |
| Sep 2007 | - | -$52.00K(-104.2%) | $77.20M(+0.4%) |
| Jun 2007 | - | $1.25M(+30.3%) | $76.93M(+17.5%) |
| Mar 2007 | - | $957.00K(-98.7%) | $65.47M(-9.0%) |
| Dec 2006 | $71.97M(+47.7%) | $75.05M(<-9900.0%) | $71.97M(-656.0%) |
| Sep 2006 | - | -$326.00K(-96.8%) | -$12.94M(-128.3%) |
| Jun 2006 | - | -$10.22M(-236.9%) | $45.68M(-19.0%) |
| Mar 2006 | - | $7.46M(-175.7%) | $56.42M(+15.8%) |
| Dec 2005 | $48.71M(-25.8%) | -$9.86M(-116.9%) | $48.71M(-13.9%) |
| Sep 2005 | - | $58.30M(>+9900.0%) | $56.58M(-15.5%) |
| Jun 2005 | - | $518.00K(-312.3%) | $66.92M(+1.6%) |
| Mar 2005 | - | -$244.00K(-87.8%) | $65.85M(+0.2%) |
| Dec 2004 | $65.69M(+473.4%) | -$2.00M(-102.9%) | $65.69M(-19.9%) |
| Sep 2004 | - | $68.64M(<-9900.0%) | $81.97M(+482.1%) |
| Jun 2004 | - | -$545.00K(+33.9%) | $14.08M(+11.3%) |
| Mar 2004 | - | -$407.00K(-102.9%) | $12.65M(+10.5%) |
| Dec 2003 | $11.46M(-234.0%) | $14.28M(+1788.4%) | $11.46M(-220.3%) |
| Sep 2003 | - | $756.00K(-138.4%) | -$9.53M(-4.7%) |
| Jun 2003 | - | -$1.97M(+22.7%) | -$9.99M(+293.2%) |
| Mar 2003 | - | -$1.60M(-76.1%) | -$2.54M(-70.3%) |
| Dec 2002 | -$8.55M(-179.4%) | -$6.71M(-2404.8%) | -$8.55M(-279.7%) |
| Sep 2002 | - | $291.00K(-94.7%) | $4.76M(-10.4%) |
| Jun 2002 | - | $5.48M(-172.0%) | $5.32M(-1576.4%) |
| Mar 2002 | - | -$7.62M(-215.3%) | -$360.00K(-103.3%) |
| Dec 2001 | $10.78M(-231.7%) | $6.61M(+680.7%) | $10.78M(-404.9%) |
| Sep 2001 | - | $846.00K(-533.8%) | -$3.53M(-31.7%) |
| Jun 2001 | - | -$195.00K(-105.5%) | -$5.17M(+83.2%) |
| Mar 2001 | - | $3.52M(-145.7%) | -$2.82M(-65.5%) |
| Dec 2000 | -$8.18M(-174.6%) | -$7.70M(+872.7%) | -$8.18M(+1611.7%) |
| Sep 2000 | - | -$792.00K(-136.8%) | -$478.00K(-252.2%) |
| Jun 2000 | - | $2.15M(-217.1%) | $314.00K(-117.1%) |
| Mar 2000 | - | -$1.84M(-117.7%) | -$1.84M(-165.3%) |
| Dec 1999 | $10.96M(-250.2%) | - | - |
| Mar 1999 | - | $10.42M(-161.6%) | $2.82M(-138.6%) |
| Dec 1998 | -$7.30M(-236.5%) | -$16.90M(-381.6%) | -$7.30M(-155.1%) |
| Sep 1998 | - | $6.00M(+81.8%) | $13.25M(+85.3%) |
| Jun 1998 | - | $3.30M(+1000.0%) | $7.15M(+53.8%) |
| Mar 1998 | - | $300.00K(-91.8%) | $4.65M(-13.1%) |
| Dec 1997 | $5.35M(+37.8%) | $3.65M(-3749.0%) | $5.35M(+53.6%) |
| Sep 1997 | - | -$100.00K(-112.5%) | $3.48M(-5.4%) |
| Jun 1997 | - | $800.00K(-20.0%) | $3.68M(-7.5%) |
| Mar 1997 | - | $1.00M(-43.9%) | $3.98M(+2.6%) |
| Dec 1996 | $3.88M(-1070.5%) | $1.78M(+1682.0%) | $3.88M(+21.3%) |
| Sep 1996 | - | $100.00K(-90.9%) | $3.20M(+39.1%) |
| Jun 1996 | - | $1.10M(+22.2%) | $2.30M(+283.3%) |
| Mar 1996 | - | $900.00K(-18.2%) | $600.00K(-250.0%) |
| Dec 1995 | -$400.00K(-130.8%) | $1.10M(-237.5%) | -$400.00K(-73.3%) |
| Sep 1995 | - | -$800.00K(+33.3%) | -$1.50M(+114.3%) |
| Jun 1995 | - | -$600.00K(+500.0%) | -$700.00K(<-9900.0%) |
| Mar 1995 | - | -$100.00K(-200.0%) | $0.00(-100.0%) |
| Dec 1994 | $1.30M(0.0%) | - | - |
| Jun 1994 | - | $100.00K(-80.0%) | $600.00K(+20.0%) |
| Mar 1994 | - | $500.00K | $500.00K |
| Dec 1993 | $1.30M | - | - |
FAQ
- What is Amedisys annual cash flow from financing activities?
- What is the all time high annual CFF for Amedisys?
- What is Amedisys annual CFF year-on-year change?
- What is Amedisys quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Amedisys?
- What is Amedisys quarterly CFF year-on-year change?
- What is Amedisys TTM cash flow from financing activities?
- What is the all time high TTM CFF for Amedisys?
- What is Amedisys TTM CFF year-on-year change?
What is Amedisys annual cash flow from financing activities?
The current annual CFF of AMED is -$48.92M
What is the all time high annual CFF for Amedisys?
Amedisys all-time high annual cash flow from financing activities is $301.57M
What is Amedisys annual CFF year-on-year change?
Over the past year, AMED annual cash flow from financing activities has changed by +$38.60M (+44.10%)
What is Amedisys quarterly cash flow from financing activities?
The current quarterly CFF of AMED is -$13.30M
What is the all time high quarterly CFF for Amedisys?
Amedisys all-time high quarterly cash flow from financing activities is $385.21M
What is Amedisys quarterly CFF year-on-year change?
Over the past year, AMED quarterly cash flow from financing activities has changed by -$4.75M (-55.56%)
What is Amedisys TTM cash flow from financing activities?
The current TTM CFF of AMED is -$53.67M
What is the all time high TTM CFF for Amedisys?
Amedisys all-time high TTM cash flow from financing activities is $387.46M
What is Amedisys TTM CFF year-on-year change?
Over the past year, AMED TTM cash flow from financing activities has changed by -$14.49M (-36.98%)